Latch, Inc. Faces Critical Liquidity, Control Issues Amidst SEC Probe and OTC Delisting

summarizeSummary

This 10-K filing reveals a company in severe distress, marked by significant financial and operational challenges. The substantial goodwill impairment, coupled with a drastic reduction in cash reserves and an explicit warning about the need for additional capital without assurance of securing it, highlights critical liquidity risks. The ongoing SEC investigation and unremediated material weaknesses in internal controls further erode investor confidence and raise serious questions about the reliability of financial reporting. The delisting from Nasdaq to the less liquid OTC market severely restricts the company's ability to raise necessary funds and impacts investor access. While there was a reduction in net loss and an improvement in Adjusted EBITDA, these positives are heavily outweighed by the fundamental issues threatening the company's long-term viability. Investors should exercise extreme caution, as the combination of these factors indicates a high risk of further value erosion and operational instability.

check_boxKey Events

• Significant Goodwill Impairment

  The company recorded a $16.6 million goodwill impairment for the year ended December 31, 2025, reducing the goodwill balance to $13.6 million. This impairment represents approximately 46% of the company's current market capitalization, indicating a substantial decline in the value of prior acquisitions.

• Severe Liquidity Concerns and Cash Burn

  Unrestricted cash and cash equivalents, along with available-for-sale securities, plummeted from $75.4 million in 2024 to $34.6 million in 2025. The company explicitly states the need to secure additional outside capital and provides no assurance it will be able to do so on acceptable terms, despite expecting to fund operations for the next 12 months.

• Ongoing SEC Investigation and Internal Control Weaknesses

  Latch, Inc. is cooperating with an ongoing SEC investigation into key performance indicators and revenue recognition practices. Furthermore, material weaknesses in internal control over financial reporting across all five COSO components remain unremediated as of December 31, 2025, raising significant concerns about financial reporting reliability.

• Delisted to OTC Market

  The company's securities were delisted from Nasdaq in August 2023 and began trading on the OTCID Basic Market in March 2026, severely limiting liquidity and access to capital for investors.

auto_awesomeAnalysis

This 10-K filing reveals a company in severe distress, marked by significant financial and operational challenges. The substantial goodwill impairment, coupled with a drastic reduction in cash reserves and an explicit warning about the need for additional capital without assurance of securing it, highlights critical liquidity risks. The ongoing SEC investigation and unremediated material weaknesses in internal controls further erode investor confidence and raise serious questions about the reliability of financial reporting. The delisting from Nasdaq to the less liquid OTC market severely restricts the company's ability to raise necessary funds and impacts investor access. While there was a reduction in net loss and an improvement in Adjusted EBITDA, these positives are heavily outweighed by the fundamental issues threatening the company's long-term viability. Investors should exercise extreme caution, as the combination of these factors indicates a high risk of further value erosion and operational instability.